PITTSBURGH—Allegheny Technologies Incorporated and Bruker Energy & Supercon Technologies (BEST), a wholly owned subsidiary of Bruker Corp., entered into a joint technology development agreement to advance state-of-the-art niobium-based superconductors, including those used in magnetic resonance imaging (MRI) magnets for the medical industry, and preclinical MRI magnets used in the life-science tools industry.
Built on a 30-year collaboration between the two companies, the agreement further extends their combined expertise to develop higher-performance niobium-based alloys and apply these alloys in improved and more efficient superconductors, which are expected to enable MRI magnets with higher performance and lower total cost of ownership.
The resulting products are expected to have applications in medical imaging, scientific instrumentation, particle physics research, and large-scale fusion experiments. The advanced manufacturing and metrology processes, as well as the highly differentiated new superconductors planned under this agreement, are expected to deliver higher performance and give healthcare providers better diagnostics. At the same time, the fully integrated supply chain will allow for process innovation to further increase efficiency, quality, and supply chain security for demanding customers.
“This long-term agreement further strengthens the extensive cooperation between ATI and Bruker,” said Burkhard Prause, Ph.D., and president of BEST, in a press release. “We believe this collaboration will further advance the combined expertise within our businesses to create new and improved superconductor products and deliver enhanced commercial value for our healthcare and life science customers.”
Bruker Energy & Supercon Technologies (www.bruker.com) is a prominent manufacturer of high- performance superconducting wire products with a product portfolio that includes niobium-based superconductors. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels.
ATI (www.ATIMetals.com) is a major producer of refractory metals and specialty alloys, materials, and components. The company has more than 50 years of experience as a manufacturer of niobium-titanium and other specialty alloys for medical and high-energy physics applications. Its largest markets are aerospace and defense, particularly jet engines, but the company also has a strong presence in the oil and gas, electrical energy, medical, automotive, and other industrial markets.
“ATI has long led the industry with its technical expertise and differentiated manufacturing capability for niobium-based alloys for superconductors,” said Lee Weber, president of ATI Specialty Alloys and Components, in the release. “This new agreement expands our collaboration, so we may create the specialty materials that will propel the industry.’